下一个

自动播放

ER+/HER2+ Metastatic Breast Cancer

2 意见 • 07/03/23
分享
嵌入
administrator
administrator
订户
0

Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放